| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |